Cargando…
Discontinuation of simvastatin leads to a rebound phenomenon and results in immediate peri‐implant bone loss
Although administration of simvastatin has been reported to promote bone formation, the effect of short‐term simvastatin administration is not well known. Following implant installation, 10‐week‐old male Wistar rats (n = 24) were divided into two groups randomly. The experimental group received 10 m...
Autores principales: | Li, Xianqi, Wu, Feng, Zhang, Yiming, Yang, Jing, Shinohara, Atsushi, Kagami, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839186/ https://www.ncbi.nlm.nih.gov/pubmed/29744151 http://dx.doi.org/10.1002/cre2.23 |
Ejemplares similares
-
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
por: Anastasilakis, Athanasios D., et al.
Publicado: (2021) -
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
por: Kim, Albert S., et al.
Publicado: (2022) -
Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
por: Anık, Ahmet
Publicado: (2022) -
Effect of local application of platelet-rich fibrin scaffold loaded with simvastatin on peri-implant bone changes
por: El Shafei, Sara Fikry, et al.
Publicado: (2022) -
Peri-Implant Bone Loss and Peri-Implantitis: A Report of Three Cases and Review of the Literature
por: John, Vanchit, et al.
Publicado: (2016)